Vanguard Group’s Endologix Inc ELGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-767,770
| Closed | -$617K | – | 4168 |
|
|
2020
Q2 | $617K | Hold |
767,770
| – | – | ﹤0.01% | 3719 |
|
|
2020
Q1 | $531K | Hold |
767,770
| – | – | ﹤0.01% | 3662 |
|
|
2019
Q4 | $1.21M | Hold |
767,770
| – | – | ﹤0.01% | 3588 |
|
|
2019
Q3 | $3.05M | Buy |
767,770
+75,419
| +11% | +$438K | ﹤0.01% | 3299 |
|
|
2019
Q2 | $5.01M | Buy |
692,351
+170,316
| +33% | +$1.16M | ﹤0.01% | 3175 |
|
|
2019
Q1 | $3.45M | Buy |
522,035
+66,416
| +15% | +$438K | ﹤0.01% | 3279 |
|
|
2018
Q4 | $3.26M | Sell |
455,619
-21,303
| -4% | -$237K | ﹤0.01% | 3226 |
|
|
2018
Q3 | $9.11M | Sell |
476,922
-78,633
| -14% | -$2.81M | ﹤0.01% | 2963 |
|
|
2018
Q2 | $31.4M | Buy |
555,555
+27,315
| +5% | +$1.39M | ﹤0.01% | 2361 |
|
|
2018
Q1 | $22.3M | Sell |
528,240
-160,982
| -23% | -$6.91M | ﹤0.01% | 2455 |
|
|
2017
Q4 | $36.9M | Buy |
689,222
+37,043
| +6% | +$1.96M | ﹤0.01% | 2217 |
|
|
2017
Q3 | $29.1M | Sell |
652,179
-11,651
| -2% | -$531K | ﹤0.01% | 2317 |
|
|
2017
Q2 | $32.3M | Buy |
663,830
+35,323
| +6% | +$2.08M | ﹤0.01% | 2240 |
|
|
2017
Q1 | $45.5M | Buy |
628,507
+30,640
| +5% | +$2.03M | ﹤0.01% | 2055 |
|
|
2016
Q4 | $34.2M | Buy |
597,867
+19,969
| +3% | +$1.83M | ﹤0.01% | 2155 |
|
|
2016
Q3 | $74M | Buy |
577,898
+20,364
| +4% | +$2.61M | ﹤0.01% | 1746 |
|
|
2016
Q2 | $69.5M | Buy |
557,534
+18,724
| +3% | +$2.15M | ﹤0.01% | 1737 |
|
|
2016
Q1 | $45M | Buy |
538,810
+91,672
| +21% | +$7.56M | ﹤0.01% | 1913 |
|
|
2015
Q4 | $44.3M | Buy |
447,138
+10,280
| +2% | +$1.1M | ﹤0.01% | 1933 |
|
|
2015
Q3 | $53.6M | Buy |
436,858
+12,186
| +3% | +$1.65M | ﹤0.01% | 1828 |
|
|
2015
Q2 | $65.1M | Buy |
424,672
+16,002
| +4% | +$2.64M | ﹤0.01% | 1791 |
|
|
2015
Q1 | $69.8M | Buy |
408,670
+20,886
| +5% | +$3.16M | ﹤0.01% | 1742 |
|
|
2014
Q4 | $59.3M | Buy |
387,784
+7,378
| +2% | +$921K | ﹤0.01% | 1744 |
|
|
2014
Q3 | $40.3M | Buy |
380,406
+12,588
| +3% | +$1.75M | ﹤0.01% | 1914 |
|
|
2014
Q2 | $55.9M | Sell |
367,818
-2,771
| -0.7% | -$369K | ﹤0.01% | 1770 |
|
|
2014
Q1 | $47.7M | Buy |
370,589
+15,777
| +4% | +$2.45M | ﹤0.01% | 1836 |
|
|
2013
Q4 | $61.9M | Buy |
354,812
+17,954
| +5% | +$3.09M | 0.01% | 1650 |
|
|
2013
Q3 | $54.3M | Buy |
336,858
+15,507
| +5% | +$2.44M | 0.01% | 1673 |
|
|
2013
Q2 | $42.7M | Buy |
+321,351
| New | +$45.4M | ﹤0.01% | 1736 |
|
Other funds holding ELGX
Vanguard Group's ELGX Position: Q3 2020 in Review
Vanguard Group sold out of Endologix Inc (ELGX) in Q3 2020, closing a stake of 767,770 shares — an estimated $617K sold.
Vanguard Group first reported a position in ELGX in Q2 2013 and held it in 29 quarters. The position peaked at $74M in Q3 2016. 6 funds tracked by Wall St. Rank hold ELGX as of Q3 2020.
- Vanguard Group reported no remaining Endologix Inc position as of Q3 2020 after selling out during the quarter.
- Vanguard Group sold 767,770 Endologix Inc shares in Q3 2020, an estimated $617K.
- Vanguard Group first reported a position in Endologix Inc in Q2 2013 and held it in 29 quarters.
- Vanguard Group's Endologix Inc position peaked at $74M in Q3 2016.
- 6 funds tracked by Wall St. Rank held Endologix Inc as of Q3 2020.
Based on Vanguard Group's 13F filing for Q3 2020, filed 16 Nov 2020.